- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- 15 states sue US Education Department over mental health cuts
- 23 new behavioral health study findings to know
- Illinois grows certified recovery support workforce 335% since 2022
- New Mexico awards $24.5M for behavioral health expansion
- HCA Houston Healthcare hospital names chief medical officer
- Indiana hospital credits expanded services to employee health insurance switch
- 38 behavioral health executive moves to know
- ChristianaCare’s Graham Cancer Center joins Association of American Cancer Institutes
- ‘The fight is worth it’: How rural hospitals can recover from the brink of closure
- The term ‘payvider’ isn’t very useful
- Hospital ACOs raised Medicare spending 0.8% under ACO REACH: 8 notes
- Payers are pushing the top anesthesiologists out of the insurance model
- Virginia’s largest dental group adds Overjet AI platform
- Healthcare ransomware attacks up 14%: 5 things to know
- UHS Texas behavioral hospital names CEO
- Pharmacy leaders are done waiting
- Mentorship vs. sponsorship: What actually gets women into health system C-suites?
- My Community Dental Centers appoints chief people officer
- Former Illinois dental employee pleads guilty to stealing more than $500K from practice
- CMS’ 2027 rules: Why some specialties are ‘on the outside looking in’
- U of Maryland appoints interim dental school dean
- CMS’ ASC rule: Gains for some, cuts for others
- What leaders need to know about rising mental health leave
- Colorado university closes dental clinic abruptly
- Principal to acquire Beam Benefits, dental provider serving 25,000 businesses
- CMS’ next payment move puts spine ASCs in focus
- The functions ASC leaders won’t hand off
- Washington’s noncompete ban: What healthcare employers need to know
- Chattanooga Heart Institute to pay $3.75M to settle data breach lawsuit
- Watson Clinic opens multispecialty ASC
- The era of free anesthesia coverage is over
- ASA, Team Health ink deal
- MaineHealth launches psychiatric nurse practitioner, physician associate fellowship
- California completes statewide behavioral health shift: 3 things to know
- 3 DSOs making headlines
- SALT Dental Partners adds 14-office North Carolina practice
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- Aspen Dental targets fast-growing Georgia city for new practice
- Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
- What will make or break the future of DSO success
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- ACA plans set for another year of premium spikes, preliminary filings show
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Foreign drugmaker caught faking doctors’ petition to evade China’s price cut scheme
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
- Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Primary care’s AI moment
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- New Medicaid Work Rule Means More Opportunities To Lose Coverage
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Epic plans to expand 4 executives' roles as President Sumit Rana exits the company
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- Regulatory tracker: NICE urges against future Lumakras reimbursement in UK
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
Michigan healthcare freedom community forum
Several business news outlets are reporting that the board of Rite Aid is considering another bankruptcy:
Rite Aid weighs repeat bankruptcy filing, WSJ reports
By Reuters - April 4, 2025April 4 (Reuters) - U.S. pharmacy chain Rite Aid is weighing a possible repeat bankruptcy after its recent financial restructuring failed to put the drugstore chain on a sustainable path, the Wall Street Journal reported on Friday.
The company has also been pursuing a sale of some or all of its businesses as a potential alternative to a Chapter 11 filing, the WSJ report said, citing people familiar with the matter.
If a sale doesn't materialize either inside or outside of bankruptcy, the pharmacy chain stands at risk of liquidating more of its footprint, the report added.
Rite Aid did not immediately respond to a Reuters request for comment.
The Pennsylvania-based company emerged from Chapter 11 bankruptcy and successfully completed its financial restructuring last year, operating as a private company.
The pharmacy has used its bankruptcy to close hundreds of stores, sell its pharmacy benefit company Elixir and negotiate settlements with its lenders, drug distribution partner McKesson (MCK.N), opens new tab and other creditors.
Rite Aid filed for Chapter 11 in October 2023, after reporting $750 million in losses and $24 billion in revenue for the fiscal year ended March 2023. It operated 2,000 pharmacies at the time of its bankruptcy.
Rite Aid says it plans to keep its 1,350 stores in 15 states open, but this may be the end for the 63 year old chain: despite filing for bankruptcy again.
https://www.upi.com/Top_News/US/2025/05/05/Rite-Aid-bankruptcy-again/2311746482815/
Rite Aid files for bankruptcy for second time in 18 months
By Allen Cone - May 5, 2025May 5 (UPI) -- Rite Aid on Monday announced it is filing for bankruptcy and looking for a new buyer, just seven months after exiting Chapter 11.
Eighteen months ago, Rite Aid first filed for bankruptcy in October 2023 because it couldn't compete against bigger chains and paid millions for filling unlawful opioid prescriptions. The company plans to keep open its 1,350 stores in 15 states with 4,000 employees.
"For more than 60 years, Rite Aid has been a proud provider of pharmacy services and products to our loyal customers," Matt Schroeder, Rite Aid's CEO, said a statement. "While we have continued to face financial challenges, intensified by the rapidly evolving retail and healthcare landscapes in which we operate, we are encouraged by meaningful interest from a number of potential national and regional strategic acquirers.
"As we move forward, our key priorities are ensuring uninterrupted pharmacy services for our customers and preserving jobs for as many associates as possible."
Rite Aid secured $1.9 billion in new financing, along with cash from operations, and is expected to provide sufficient funding during the sale and court-supervised process," according to a Rite Aid release.
The company intends to divest or monetize any assets not sold through the court-supervised process.
During the first Chapter 11 process, the company slashed $2 billion in debt, secured $2.5 billion in funds to keep operating and closed about 500 locations.
Rite Aid, which is headquartered in Philadelphia, had revenue of $24.06 billion in 2023 but a $750 million net loss, according to its filing.
Rite Aid is the third-largest nationwide standalone pharmacy chain in the United States far behind CVS's 9,118 and Walgreens with 8,363. CVS also has 1,865 retail pharmacies within retail chains and approximately 80 clinics in Target stores.
When counting big box chains, such as Walmart, it is the seventh-largest pharmacy in the United States. Also Amazon is now selling prescription drugs.
In 2015, Walgreens offered $17 billion to acquire the company, but U.S. regulators were fearful the combination would violate federal antitrust laws and reduce competition in the market.
In 2017, the companies agreed to a $4.4 billion deal in which Walgreens acquired 1,932 of the 4,000 Rite Aid locations.
Rite Aid's peak in 2008 was 5,059 stores. Rite Aid opened its first store in 1962 in Scranton, Pa., and now is mainly in New York, California and Pennsylvania.
Walgreens announced in March that it was going private in a deal valued up to $24 billion. The transaction is expected to be finalized later this year.
CVS has closed more than 1,000 stores and undergone thousands of layoffs.
Rite Aid has begun selling off its "pharmacy assets". In some cases entire stores, in others prescription and customer files:
Rite Aid to sell 1,000 pharmacy assets to CVS, Walgreens and others
By Sabrina Valle - May 15, 2025May 15 (Reuters) - Bankrupt U.S. pharmacy chain Rite Aid on Thursday said it agreed to sell pharmacy assets from more than 1,000 store locations in separate transactions to CVS Pharmacy, Walgreens, Albertsons, Kroger and Giant Eagle, among others.
CVS Pharmacy will buy and operate many Rite Aid and Bartell Drugs stores in Washington, Oregon and Idaho, Rite Aid said in a filing.
Rite Aid stores will remain open, and customers can continue to use pharmacy services, including prescription refills and immunizations, without interruption, it said.
The sale includes prescription files and other goods, a person familiar with the agreements said.
Walgreens declined to comment. The other bidders did not immediately respond to requests for comment.
Earlier this month, Rite Aid filed for bankruptcy for the second time in less than two years, after poor performance in its retail business made it difficult for the company to maintain sufficient cash flow and restock its retail inventory.
The company has received court approval to pursue a rapid-fire sale of its pharmacy business. Rite Aid is scheduled to conduct a hearing to approve the sales on May 21. The sales will remain subject to regulatory notices and approvals.
The Pennsylvania-based company entered bankruptcy with over $2 billion in debt and has warned employees about likely job cuts. Rite Aid Chief Executive Matt Schroeder said on Thursday the company would try to preserve jobs during the transition.
"These agreements ensure our pharmacy customers will experience a smooth transition while preserving jobs for some of our valued team members," Schroeder said in a note.
Bloomberg had previously reported on CVS' bid.
Rite Aid had about 1,350 pharmacies, so the fate of the remaining 350 pharmacies is yet to be explained.
And they're gone for good:
https://www.cbsnews.com/news/rite-aid-closing-all-locations-after-decades-in-business/
Rite Aid closing all locations after decades in business
October 4, 2025 / 9:34 PM EDT / CBS NewsRite Aid is closing all locations, according to a recent post on the U.S. pharmacy chain's website.
"All Rite Aid stores have now closed. We thank our loyal customers for their many years of support," read a post at the bottom of the Rite Aid website.
CBS News reached out to Rite Aid for comment on Saturday.
Rite Aid filed for bankruptcy in May, the second such filing in nearly two years. The company also filed for bankruptcy in October 2023 and said at the time that the restructuring would "significantly reduce the company's debt" while helping to "resolve litigation claims in an equitable manner." Rite Aid said it planned to close down 154 stores after the filing.
The company obtained $3.45 billion in fresh financing as it carried out a restructuring plan and dealt with dips in sales and opioid-related lawsuits.
More than 520 Rite Aid pharmacies have closed since October 2023, which is about a quarter of the 2,111 open at the time of the bankruptcy filing.
The Justice Department filed a complaint against Rite Aid in March 2023, accusing the company of violating the False Claims Act and the Controlled Substances Act by filling unlawful prescriptions for drugs such as oxycodone, fentanyl and benzodiazepine and ignoring internal red flags about the prescriptions, CBS News reported.
The website for the company founded in 1962 now only shows a service to help former customers find a new pharmacy and a link to request pharmacy records.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























